For Mylan World TeamTennis, the word “access” is taken one step further. Before young fans had the chance to connect with the exciting action of a professional tennis match, they were given access to ...

Pharmaceutical firm Mylan is dramatically expanding a nationwide recall of some blood pressure medications after detecting trace amounts of a chemical linked to cancer. The recalled products all ...

Mylan announced on its most recent quarterly earnings call that it expects to launch its rituximab and etanercept biosimilars in Europe later this year. In discussing Mylan’s biosimilars pipeline, ...

Mylan's planned megamerger with Pfizer's Upjohn generics unit has had a rocky road to approval, with the novel coronavirus pandemic snagging regulatory review. Despite the delay, Mylan isn't twiddling ...

One of the world’s largest generic drugmakers and a division of one of the largest pharmaceutical companies are combining to create a new pharmaceutical company. Pittsburgh-based Mylan and Upjohn – ...

On Sept. 27, 2019, the Securities and Exchange Commission (SEC) announced that Mylan N.V., a global pharma company that manufactures and sells EpiPen, which is used to treat serious allergic reactions ...

PITTSBURGH (KDKA/AP) -- Pfizer is buying Mylan in an all-stock deal and combining the $10 billion generic pharmaceutical company with its own off-patent branded and generic business. The Pfizer ...

Mylan has spent more than $460 million buying Novartis cystic fibrosis products. Now, it wants the plant that makes them. Mylan took an option on a Novartis plant in San Carlos, California, when it ...

Mylan on Sept. 8 signed a deal to acquire South African drugmaker Aspen Pharmacare’s thrombosis business in Europe for $757 million. The Canonsburg, Pa.-based drugmaker will gain rights for Aspen’s ...

Mylan finalized a $465 million DOJ settlement in an effort to put its EpiPen drama in the rearview mirror. Amanda Pedersen Mylan CEO Heather Bresch said the company's finalized settlement brings ...

Pfizer shareholders would own 57% of the new company and Mylan's shareholders would get 43%. The combined company, which will sell Mylan's EpiPen and Pfizer's Viagra, will be domiciled in the U.S. The ...

One company makes Xanax and Viagra. The other makes the popular EpiPen drug for people with allergies. Now they may be close to merging. The Wall Street Journal reported Saturday that pharma giants ...